RecruitingNot ApplicableNCT04347759

Symptom Care at Home-Heart Failure

Symptom Care at Home-Heart Failure: Developing and Piloting a Symptom Monitoring and Self-Management Coaching System for Patients With Heart Failure


Sponsor

Emory University

Enrollment

50 participants

Start Date

Feb 12, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This project aims to adapt a computer-interface telephonic interactive voice response system that monitors symptoms and provides real-time, self-management coaching messages based on heart failure patient-reported outcomes.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a phone-based symptom monitoring system for people with heart failure who are returning home from the hospital. The system checks in with patients regularly about their symptoms and helps them and their care team respond quickly to warning signs before things get worse. **You may be eligible if:** - You have a diagnosis of heart failure - Your heart failure is classified as any stage (NYHA Class I–IV) - You can read, understand, and speak English - You are being discharged home (not to a facility) - You have daily access to any type of phone **You may NOT be eligible if:** - You show signs of significant cognitive impairment based on a brief memory test - You are being discharged home on hospice (end-of-life) care - You have end-stage kidney failure - You are on a waiting list for a heart transplant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALCoaching Messages

Participants receive real-time self-management coaching messages based on the severity of their symptoms. When participants call, the IVR system will ask them about each of the selected symptoms, and the patient will report symptom presence and severity numerically with the touch-tone keypad.

BEHAVIORALAutomated Daily Monitoring

Participants report daily symptoms and symptom severity. There are three categories of severity based on a numeric scale of 1 to 3 for mild symptoms, 4 to 7 for moderate symptoms, and 8 to 10 for severe symptoms.


Locations(4)

Emory University Hospital Midtown

Atlanta, Georgia, United States

Emory Clinic

Atlanta, Georgia, United States

Emory University Hospital

Atlanta, Georgia, United States

University of Utah Health

Salt Lake City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04347759


Related Trials